W.E. Fibbe

Donor Lymphocyte Infusions for Relapsed Multiple Myeloma After Allogeneic Stem-Cell Transplantation: Predictive Factors for Response and Long-Term Outcome

H M Lokhorst, A Schattenberg, Jan J. Cornelissen et al. · Journal of Clinical Oncology · 2000 · 287 citations

Overall and event-free survival are not improved by the use of myeloablative therapy following intensified chemotherapy in previously untreated patients with multiple myeloma: a prospective randomized phase 3 study

Christine M. Segeren, Pieter Sonneveld, Bronno van der Holt et al. · Blood · 2003 · 163 citations · Full text

Generation of mesenchymal stromal cells in the presence of platelet lysate: a phenotypic and functional comparison of umbilical cord blood- and bone marrow-derived progenitors

Maria Antonietta Avanzini, Maria Ester Bernardo, Angela Cometa et al. · Haematologica · 2009 · 116 citations · Full text

Vincristine, doxorubicin and dexamethasone (VAD) administered as rapid intravenous infusion for first‐line treatment in untreated multiple myeloma

Christine M. Segeren, Pieter Sonneveld, Bronno van der Holt et al. · British Journal of Haematology · 1999 · 98 citations · Full text

SERUM TRANSFORMING GROWTH FACTOR-??1 LEVELS IN BONE MARROW TRANSPLANT RECIPIENTS CORRELATE WITH BLOOD CELL COUNTS AND CHRONIC GRAFT-VERSUS-HOST DISEASE1

Linda M. Liem, W.E. Fibbe, Hans C. van Houwelingen et al. · Transplantation · 1999 · 83 citations